Company overview
Basic information
Company name
Plunksnos Istorija, MB
Company code
306337479
VAT code
LT100016062515
Registered address
Klaipėdos r. sav., Sendvario sen., Trušelių k., Agnytės g. 13, LT-92337
Registration date
2023-06-14
Company age: 3 y. 4 mo.
Contact information
Edit data
Phone
Presented as an image – cannot be copied
Email
Not disclosed
(personal)
Website
https://[email protected]
Company manager
For registered members only
Log in
Indicators
Risk factors
Activity
Legal form
Small partnership
NACE activity
Activities of advertising agencies
Ownership form
Private without foreign capital
MB "Plunksnos Istorija"
Company code: 306337479
Address: Klaipėdos r. sav., Sendvario sen., Trušelių k., Agnytės g. 13, LT-92337
VAT code: LT100016062515
Description
This description was generated by artificial intelligence.
Plunksnos Istorija, MB (company code 306337479) is an operational private small partnership registered on 14 June 2023. It operates as a micro-sized entity within the sector of national private non-financial companies and is owned under private ownership, where Lithuanian natural and legal persons hold more than 50% of the authorised capital and there is no foreign investor capital. Governance is described as CEO only. The company is based in Trušeliu k., Sendvario sen., Klaipedos r. sav., Klaipedos apskr. Its registered activity is N.73.11.00, Activities of advertising agencies. Financially, the company generated EUR 26.9K in revenue in 2025, down 24.6% year on year after EUR 35.7K in 2024. Net profit was EUR 61 in 2025, compared with EUR 5.4K in 2024, and the net profit margin fell to 0.2% from 15.1% a year earlier. Over the two-year period, revenue remained above the 2023 level of EUR 24.9K, while profitability weakened significantly. Staff data shows an average of 1 employee in both 2023 and 2024.
Download a detailed company report
Make confident decisions with all the information about Plunksnos Istorija, MB. In one document, you will find full financial data, risk and potential assessment, and key Scoris insights.